Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is one of the most common endocrine/metabolic disorders found in women, affecting approximately 105 million women worldwide. It is characterized by ovulatory dysfunction, often presenting as oligomenorrhea or amenorrhea and either clinical or biochemical hyperandroge...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathur, Ruchi, Levin, Olga, Azziz, Ricardo
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504056/
https://www.ncbi.nlm.nih.gov/pubmed/18728832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504056/
https://www.ncbi.nlm.nih.gov/pubmed/18728832

Ejemplares similares